Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Manczak

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Human Molecular Genetics|January 25, 2011
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damageUlziibat Shirendeb, Arubala P Reddy, Maria Manczak, et al.
Journal of Alzheimer'S Disease : JAD|April 27, 2005
Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunctionP Hemachandra Reddy, Geethalakshmi Mani, Byung S Park, et al.
Human Molecular Genetics|October 15, 2011
Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's diseaseUlziibat P Shirendeb, Marcus J Calkins, Maria Manczak, et al.
International Journal of Environmental Research and Public Health|February 15, 2011
Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31Tejaswini P Reddy, Maria Manczak, Marcus J Calkins, et al.
Biochimica Et Biophysica Acta|November 8, 2011
Mitochondrial DNA deletions and differential mitochondrial DNA content in Rhesus monkeys: implications for agingPeizhong Mao, Patience Gallagher, Samira Nedungadi, et al.
Journal of Alzheimer'S Disease : JAD|May 14, 2010
Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neuronsMaria Manczak, Peizhong Mao, Marcus J Calkins, et al.
Mitochondrion|February 27, 2021
Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ miceJasvinder Singh Bhatti, Kavya Tamarai, Ramesh Kandimalla, et al.
Human Molecular Genetics|April 30, 2004
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's diseaseP Hemachandra Reddy, Shannon McWeeney, Byung S Park, et al.
Human Molecular Genetics|April 12, 2012
Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extensionPeizhong Mao, Maria Manczak, Marcus J Calkins, et al.
Biochimica Et Biophysica Acta|November 1, 2011
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeuticsP Hemachandra Reddy, Raghav Tripathi, Quang Troung, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Human Molecular Genetics|January 25, 2011
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damageUlziibat Shirendeb, Arubala P Reddy, Maria Manczak, et al.
Journal of Alzheimer'S Disease : JAD|April 27, 2005
Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunctionP Hemachandra Reddy, Geethalakshmi Mani, Byung S Park, et al.
Human Molecular Genetics|October 15, 2011
Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's diseaseUlziibat P Shirendeb, Marcus J Calkins, Maria Manczak, et al.
International Journal of Environmental Research and Public Health|February 15, 2011
Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31Tejaswini P Reddy, Maria Manczak, Marcus J Calkins, et al.
Biochimica Et Biophysica Acta|November 8, 2011
Mitochondrial DNA deletions and differential mitochondrial DNA content in Rhesus monkeys: implications for agingPeizhong Mao, Patience Gallagher, Samira Nedungadi, et al.
Journal of Alzheimer'S Disease : JAD|May 14, 2010
Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neuronsMaria Manczak, Peizhong Mao, Marcus J Calkins, et al.
Mitochondrion|February 27, 2021
Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ miceJasvinder Singh Bhatti, Kavya Tamarai, Ramesh Kandimalla, et al.
Human Molecular Genetics|April 30, 2004
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's diseaseP Hemachandra Reddy, Shannon McWeeney, Byung S Park, et al.
Human Molecular Genetics|April 12, 2012
Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extensionPeizhong Mao, Maria Manczak, Marcus J Calkins, et al.
Biochimica Et Biophysica Acta|November 1, 2011
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeuticsP Hemachandra Reddy, Raghav Tripathi, Quang Troung, et al.
Pageof 6